Motus GI Holdings, Inc.
MOTSDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
RM-131 | Phase 2 | Diabetes Mellitus | - | - |
Frequently asked questions
What is in Motus GI Holdings, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Motus GI Holdings, Inc.'s (MOTS) pipeline across Phase 2. Its lead program is RM-131 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Motus GI Holdings, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Motus GI Holdings, Inc. (MOTS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track MOTS biotech catalysts?→
Add MOTS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Motus GI Holdings, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.